ClinicalTrials.gov record
Recruiting No phase listed Observational

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease

ClinicalTrials.gov ID: NCT04991831

Public ClinicalTrials.gov record NCT04991831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 5:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT04991831
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
InSightec
Industry
Enrollment
50 participants

Conditions and interventions

Interventions

  • Unilateral thalamotomy Device

Device

Eligibility (public fields only)

Age range
30 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2022
Primary completion
Nov 30, 2027
Completion
Nov 30, 2027
Last update posted
Mar 19, 2026

2022 – 2027

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Miami Neuroscience Institute Baptist Health Miami Florida 33176 Recruiting
Rush University Chicago Illinois 60612 Recruiting
Brigham and Women's Hospital Boston Massachusetts 02115 Recruiting
Weill Cornell Medicine New York New York 10065 Recruiting
Novant Health Brain & Spine Surgery Huntsville North Carolina 28708 Recruiting
Cleveland Clinic Foundation Cleveland Ohio 44195 Recruiting
Miami Valley Hospital Fairborn Ohio 45324 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04991831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2026 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04991831 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →